We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

7 hedge funds and large institutions have $361K invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 7 → 7 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

22% less capital invested

Capital invested by funds: $462K → $361K (-$101K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$4.29K

Top Sellers

Rank Fund Capital Flow
1
SSG
Summit Securities Group
New York
-$6K
2
TRCT
Tower Research Capital (TRC)
New York
-$165

VBIV Hedge Fund Activity: Q4 2013 in Review

7 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q4 2013, worth a combined $361K — down 22% from $462K a quarter earlier.

Fund positioning in VBIV was balanced in Q4 2013: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was UBS, opening a new position worth an estimated $4.29K. The largest seller was Summit Securities Group, exiting entirely with an estimated $6K sold.

  • 7 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $361K of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q4 2013, down 22% quarter-over-quarter.
  • 1 fund opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q4 2013 and 1 closed out, a net change of 0 holders.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q4 2013 was UBS, an estimated $4.29K added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q4 2013 was Summit Securities Group, an estimated $6K sold.

Based on aggregated 13F filings for Q4 2013.